Skip to main content
. 2020 Mar 31;21(7):2437. doi: 10.3390/ijms21072437

Table 6.

Characteristics of cases and controls, data gained at follow-up.

Normotensive Term Pregnancies
(n = 89)
GDM on Diet Only
(n = 93)
GDM on Diet and Therapy
(n = 18)
p-value1 p-value2
Age (years) 38.33 ± 0.38 38.70 ± 0.37 38.61 ± 0.80 0.465 0.564
Time elapsed since delivery (years) 5.75 ± 0.20 5.49 ± 0.12 5.33 ± 0.20 0.965 0.045
BMI 23.15 ± 0.38 23.85 ± 0.37 27.21 ± 0.83 1.000 1.000
Normal (< 25) 67 (75.28%) 70 (75.27%) 5 (27.78%) 0.633 < 0.001
Overweight (≥ 25 <30) 18 (20.22%) 16 (17.20%) 9 (50.00%)
Obese (≥ 30) 4 (4.49%) 7 (7.53%) 4 (22.22%)
Smoking - -
Non-Smoker 54 (60.67%) 78 (83.87%) 16 (88.88%)
Ex-smoker 21 (23.60%) 6 (6.45%) 2 (11.11%)
Smoker 14 (15.73%) 9 (9.68%) 0 (0%)
Angina or heart attack in a first degree relative before the age of 60 years 2 (2.22%) 6 (6.45%) 2 (11.11%) - -
Atrial fibrillation 0 (0%) 0 (0%) 0 (0%) - -
DM type I 0 (0%) 0 (0%) 0 (0%) - -
DM type II 0 (0%) 0 (0%) 0 (0%) - -
Fasting serum glucose levels - -
Normal (3.33–5.59 mmol/L) 89 (100.0%) 90 (96.77%) 18 (100.0%)
High (> 5.59 mmol/L) 0 (0%) 3 (3.23%) 0 (0%)
Fasting serum total cholesterol levels - -
Normal (2.9–5.0 mmol/L) 43 (48.31%) 51 (54.84%) 10 (55.55%)
High (> 5.0–7.9 mmol/L) 46 (51.69%) 41(44.09%) 8 (44.44%)
Critical (≥ 8.0 mmol/L) 0 (0%) 1 (1.08%) 0 (0%)
Fating serum LDL cholesterol levels 0.987 0.281
Normal (1.2–3.0 mmol/L) 42 (47.19%) 44 (47.31%) 6 (33.33%)
High (> 3.0 mmol/L) 47 (52.81%) 49 (52.69%) 12 (66.67%)
SBP - -
Normal (< 140 mmHg) 89 (100.0%) 92 (98.92%) 18 (100.0%)
High (≥ 140–179 mmHg) 0 (0%) 1 (1.08%) 0 (0%)
Critical (≥ 180 mmHg) 0 (0%) 0 (0%) 0 (0%)
DBP - -
Normal (< 90 mmHg) 88 (98.88%) 90 (96.77%) 17 (94.44%)
High (≥ 90–109 mmHg) 1 (1.12%) 3 (3.23%) 1 (5.56%)
Critical (≥ 110 mmHg) 0 (0%) 0 (0%) 0 (0%)
On blood pressure treatment 0 (0%) 0 (0%) 0 (0%) - -
Chronic kidney disease 0 (%) 1 (0.98%)
Chronic renal insufficiency
0 (0%) - -
Chronic venous insufficiency 0 (0%) 0 (0%) 0 (0%) - -
Thrombosis 0 (0%) 2 (2.15%) 0 (0%) - -
Relative QRISK®3-2018 risk score 0.926 ± 0.05 0.889 ± 0.04 1.022 ± 0.08 1.0 1.0
Hormonal contraceptive use 0.040 0.474
No 12 (13.48%) 5 (5.38%) 2 (11.11%)
In the past 63 (70.79%) 80 (86.02%) 15 (83.33%)
Yes 14 (15.73%) 8 (8.60%) 1 (5.56%)
Total number of pregnancies per patient 0.924 0.440
1 9 (10.11%) 8 (8.60%) 2 (11.11%)
2 44 (49.44%) 48 (51.61%) 6 (33.33%)
3+ 36 (40.45%) 37 (39.78%) 10 (55.55%)
Total parity per patient 0.991 0.217
1 13 (14.61%) 13 (13.98%) 2 (11.11%)
2 62 (69.66%) 65 (69.89%) 10 (55.55%)
3+ 14 (15.73%) 15 (16.13%) 6 (33.33%)

Data are presented as mean ± SE for continuous variables and as number (percent) for categorical variables. Statistically significant results are marked in bold. Continuous variables were compared using Mann–Whitney test. p-value1, the comparison among normal pregnancies and GDM on diet; p-value2, the comparison among normal pregnancies and GDM on diet and therapy, respectively. Categorical variables were compared using a chi-square test. GA, gestational age; SBP, systolic blood pressure; DBP, diastolic blood pressure; CS, caesarean section.